On 9 November 2019, members of the International Relapsing Polychondritis Research Network (IRPRN) met at The American Hotel in Atlanta, GA to (1) provide an update on the relapsing polychondritis (RP) classification criteria project, (2) introduce a new project to modify the RP disease activity index, and (3) discuss ongoing and recently completed RP-related projects.
Thank you to the highly skilled, collaborative, global experts — with a broad range of specialties and disciplines — for meeting to advance research to facilitate treatments and a cure for RP.
International Relapsing Polychondritis Research Network Meeting
The Race for RP and the RP Foundation and were most pleased to facilitate the IRPRN meeting and look forward to supporting future collaborative meetings that benefit the RP and autoimmune disease communities.
RP is a debilitating autoimmune condition characterized by recurrent inflammation of cartilage and other tissues throughout the body. The disease, which can be fatal, affects multiple organs, particularly cartilaginous structures such as the ears, nose, airways and joints as well as eyes, skin, heart valves and brain. The signs and symptoms vary from person to person depending on which parts of the body are affected.